The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | Sell(S) | 5K | $18.00 | $84K |
| Jul 1, 2026 | Dube Michael P | VP, Chief Accounting Officer | Sell(S) | 3K | $16.78 | $44K |
| Jun 9, 2026 | Bhanji Muna | Director | Grant(A) | 9K | — | $0 |
| Jun 9, 2026 | Bhanji Muna | Director | Grant(A) | 13K | — | $0 |
| Jun 9, 2026 | Verwiel Frank | Director | Grant(A) | 9K | — | $0 |
| Jun 9, 2026 | Verwiel Frank | Director | Grant(A) | 13K | — | $0 |
| Jun 9, 2026 | Keresty Georgia | Director | Grant(A) | 9K | — | $0 |
| Jun 9, 2026 | Keresty Georgia | Director | Grant(A) | 13K | — | $0 |
| Jun 9, 2026 | Goodman Jesse | Director | Grant(A) | 9K | — | $0 |
| Jun 9, 2026 | Goodman Jesse | Director | Grant(A) | 13K | — | $0 |
| Jun 9, 2026 | Goff Brian | Director | Grant(A) | 9K | — | $0 |
| Jun 9, 2026 | Goff Brian | Director | Grant(A) | 13K | — | $0 |
| Jun 9, 2026 | Cohen Fred E | Director | Grant(A) | 9K | — | $0 |
| Jun 9, 2026 | Cohen Fred E | Director | Grant(A) | 13K | — | $0 |
| Jun 9, 2026 | Chase William J | Director | Grant(A) | 9K | — | $0 |
| Jun 9, 2026 | Chase William J | Director | Grant(A) | 13K | — | $0 |
| Mar 2, 2026 | Clark Eliana | EVP, Chief Technical Officer | Sell(S) | 607 | $13.78 | $8K |
| Mar 2, 2026 | Basta James | EVP, General Counsel | Sell(S) | 1K | $13.78 | $17K |
| Mar 1, 2026 | Dube Michael P | VP, Chief Accounting Officer | Grant(A) | 17K | — | $0 |
| Mar 1, 2026 | Clark Eliana | EVP, Chief Technical Officer | Grant(A) | 7K | — | $0 |
| Mar 1, 2026 | Clark Eliana | EVP, Chief Technical Officer | Grant(A) | 11K | — | $0 |
| Mar 1, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | Grant(A) | 39K | — | $0 |
| Mar 1, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | Grant(A) | 56K | — | $0 |
| Mar 1, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | Grant(A) | 61K | — | $0 |
| Mar 1, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | Grant(A) | 88K | — | $0 |
| Mar 1, 2026 | Lebwohl David | EVP, Chief Medical Officer | Grant(A) | 10K | — | $0 |
| Mar 1, 2026 | Lebwohl David | EVP, Chief Medical Officer | Grant(A) | 14K | — | $0 |
| Mar 1, 2026 | Basta James | EVP, General Counsel | Grant(A) | 46K | — | $0 |
| Mar 1, 2026 | Basta James | EVP, General Counsel | Grant(A) | 66K | — | $0 |
| Mar 1, 2026 | Leonard John M | President and CEO, Director | Grant(A) | 156K | — | $0 |
| Mar 1, 2026 | Leonard John M | President and CEO, Director | Grant(A) | 225K | — | $0 |
| Jan 5, 2026 | Dube Michael P | VP, Chief Accounting Officer | Sell(S) | 3K | $9.21 | $28K |
| Jan 5, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | Sell(S) | 6K | $9.21 | $59K |
| Jan 5, 2026 | Clark Eliana | EVP, Chief Technical Officer | Sell(S) | 10K | $9.21 | $88K |
| Jan 5, 2026 | Lebwohl David | EVP, Chief Medical Officer | Sell(S) | 12K | $9.21 | $110K |
| Jan 5, 2026 | Cohen Fred E | Director | Buy(P) | 150K | $9.35 | $1.4M |
| Jan 5, 2026 | Basta James | EVP, General Counsel | Sell(S) | 10K | $9.21 | $96K |
| Jan 5, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | Sell(S) | 9K | $9.21 | $78K |
| Jan 5, 2026 | Leonard John M | President and CEO, Director | Sell(S) | 34K | $9.21 | $314K |
| Dec 12, 2025 | Leonard John M | President and CEO, Director | Option exercise(M) | 9K | $6.83 | $58K |
| Dec 12, 2025 | Leonard John M | President and CEO, Director | Option exercise(M) | 9K | — | $0 |
| Dec 11, 2025 | Leonard John M | President and CEO, Director | Option exercise(M) | 50K | $6.83 | $341K |
| Dec 11, 2025 | Leonard John M | President and CEO, Director | Sell(S) | 5K | $9.59 | $51K |
| Dec 11, 2025 | Leonard John M | President and CEO, Director | Sell(S) | 33K | $9.47 | $311K |
| Dec 11, 2025 | Leonard John M | President and CEO, Director | Sell(S) | 50K | $9.49 | $474K |
| Dec 11, 2025 | Leonard John M | President and CEO, Director | Option exercise(M) | 50K | — | $0 |
| Oct 1, 2025 | Dube Michael P | VP, Chief Accounting Officer | Sell(S) | 2K | $17.38 | $33K |
| Oct 1, 2025 | Schultes Birgit C | EVP, Chief Scientific Officer | Sell(S) | 31 | $17.38 | $539 |
| Aug 20, 2025 | Chase William J | Director | Buy(P) | 100K | $10.03 | $1.0M |
| Jul 23, 2025 | Dulac Edward J III | EVP, Chief Financial Officer | Sell(S) | 7K | $14.02 | $105K |
| Jul 2, 2025 | Dube Michael P | VP, Chief Accounting Officer | Sell(S) | 3K | $9.95 | $25K |
| Jul 1, 2025 | Goodman Jesse | Director | Sell(S) | 2K | $9.23 | $14K |
| Jul 1, 2025 | Clark Eliana | EVP, Chief Technical Officer | Sell(S) | 1K | $9.82 | $10K |
| Jun 30, 2025 | Goodman Jesse | Director | Sell(S) | 2K | $9.56 | $15K |
| Jun 11, 2025 | Cohen Fred E | Director | Grant(A) | 8K | — | $0 |
| Jun 11, 2025 | Cohen Fred E | Director | Grant(A) | 11K | — | $0 |
| Jun 11, 2025 | Chase William J | Director | Grant(A) | 8K | — | $0 |
| Jun 11, 2025 | Chase William J | Director | Grant(A) | 11K | — | $0 |
| Jun 11, 2025 | Bhanji Muna | Director | Grant(A) | 8K | — | $0 |
| Jun 11, 2025 | Bhanji Muna | Director | Grant(A) | 11K | — | $0 |
| Jun 11, 2025 | Goff Brian | Director | Grant(A) | 8K | — | $0 |
| Jun 11, 2025 | Goff Brian | Director | Grant(A) | 11K | — | $0 |
| Jun 11, 2025 | Goodman Jesse | Director | Grant(A) | 8K | — | $0 |
| Jun 11, 2025 | Goodman Jesse | Director | Grant(A) | 11K | — | $0 |
| Jun 11, 2025 | Verwiel Frank | Director | Grant(A) | 8K | — | $0 |
| Jun 11, 2025 | Verwiel Frank | Director | Grant(A) | 11K | — | $0 |
| Jun 11, 2025 | Keresty Georgia | Director | Grant(A) | 8K | — | $0 |
| Jun 11, 2025 | Keresty Georgia | Director | Grant(A) | 11K | — | $0 |
| Apr 29, 2025 | Bhanji Muna | Director | Sell(S) | 265 | $8.50 | $2K |
| Mar 4, 2025 | Basta James | EVP, General Counsel | Sell(S) | 3K | $8.99 | $23K |
| Mar 4, 2025 | Clark Eliana | EVP, Chief Technical Officer | Sell(S) | 679 | $8.99 | $6K |
| Mar 1, 2025 | Basta James | EVP, General Counsel | Grant(A) | 40K | — | $0 |
| Mar 1, 2025 | Basta James | EVP, General Counsel | Grant(A) | 57K | — | $0 |
| Mar 1, 2025 | Schultes Birgit C | EVP, Chief Scientific Officer | Grant(A) | 38K | — | $0 |
| Mar 1, 2025 | Schultes Birgit C | EVP, Chief Scientific Officer | Grant(A) | 54K | — | $0 |
| Mar 1, 2025 | Lebwohl David | EVP, Chief Medical Officer | Grant(A) | 43K | — | $0 |
| Mar 1, 2025 | Lebwohl David | EVP, Chief Medical Officer | Grant(A) | 62K | — | $0 |
| Mar 1, 2025 | Dube Michael P | VP, Chief Accounting Officer | Grant(A) | 14K | — | $0 |
| Mar 1, 2025 | Dulac Edward J III | EVP, Chief Financial Officer | Grant(A) | 47K | — | $0 |
| Mar 1, 2025 | Dulac Edward J III | EVP, Chief Financial Officer | Grant(A) | 67K | — | $0 |
| Mar 1, 2025 | Leonard John M | President and CEO, Director | Grant(A) | 136K | — | $0 |
| Mar 1, 2025 | Leonard John M | President and CEO, Director | Grant(A) | 196K | — | $0 |
| Mar 1, 2025 | Clark Eliana | EVP, Chief Technical Officer | Grant(A) | 32K | — | $0 |
| Mar 1, 2025 | Clark Eliana | EVP, Chief Technical Officer | Grant(A) | 46K | — | $0 |
| Jan 29, 2025 | Bhanji Muna | Director | Sell(S) | 265 | $9.97 | $3K |
| Jan 3, 2025 | Clark Eliana | EVP, Chief Technical Officer | Sell(S) | 7K | $12.18 | $90K |
| Jan 3, 2025 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Sell(S) | 9K | $12.18 | $109K |
| Jan 3, 2025 | Leonard John M | President and CEO, Director | Sell(S) | 27K | $12.18 | $327K |
| Jan 3, 2025 | Hicks Derek | EVP, Chief Business Officer | Sell(S) | 7K | $12.18 | $79K |
| Jan 3, 2025 | Lebwohl David | EVP, Chief Medical Officer | Sell(S) | 10K | $12.18 | $116K |
| Jan 3, 2025 | Basta James | EVP, General Counsel | Sell(S) | 7K | $12.18 | $86K |
| Jan 3, 2025 | Dube Michael P | VP, Chief Accounting Officer | Sell(S) | 1K | $12.18 | $17K |
| Jan 2, 2025 | Clark Eliana | EVP, Chief Technical Officer | Sell(S) | 556 | $12.03 | $7K |
| Jan 1, 2025 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Option exercise(M) | 4K | — | — |
| Jan 1, 2025 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Option exercise(M) | 4K | — | $0 |
| Jan 1, 2025 | Leonard John M | President and CEO, Director | Option exercise(M) | 8K | — | — |
| Jan 1, 2025 | Leonard John M | President and CEO, Director | Option exercise(M) | 8K | — | $0 |
| Jan 1, 2025 | Lebwohl David | EVP, Chief Medical Officer | Option exercise(M) | 3K | — | — |
| Jan 1, 2025 | Lebwohl David | EVP, Chief Medical Officer | Option exercise(M) | 3K | — | $0 |
| Oct 2, 2024 | Dube Michael P | VP, Chief Accounting Officer | Sell(S) | 2K | $19.01 | $38K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).